Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $210.37 million. The enterprise value is -$31.52 million.
| Market Cap | 210.37M |
| Enterprise Value | -31.52M |
Important Dates
The last earnings date was Monday, August 3, 2026, after market close.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 19.83 million shares outstanding. The number of shares has decreased by -33.15% in one year.
| Current Share Class | 19.83M |
| Shares Outstanding | 19.83M |
| Shares Change (YoY) | -33.15% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 3.05% |
| Owned by Institutions (%) | 89.68% |
| Float | 17.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.46 |
| Forward PS | 12.37 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.96, with a Debt / Equity ratio of 0.06.
| Current Ratio | 21.96 |
| Quick Ratio | 21.47 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.16% and return on invested capital (ROIC) is -481.72%.
| Return on Equity (ROE) | -17.16% |
| Return on Assets (ROA) | -11.78% |
| Return on Invested Capital (ROIC) | -481.72% |
| Return on Capital Employed (ROCE) | -35.75% |
| Weighted Average Cost of Capital (WACC) | 9.08% |
| Revenue Per Employee | $163,196 |
| Profits Per Employee | -$903,902 |
| Employee Count | 92 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.97% in the last 52 weeks. The beta is 1.01, so KROS's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -27.97% |
| 50-Day Moving Average | 10.60 |
| 200-Day Moving Average | 13.99 |
| Relative Strength Index (RSI) | 48.48 |
| Average Volume (20 Days) | 206,991 |
Short Selling Information
The latest short interest is 985,590, so 4.97% of the outstanding shares have been sold short.
| Short Interest | 985,590 |
| Short Previous Month | 1.06M |
| Short % of Shares Out | 4.97% |
| Short % of Float | 5.53% |
| Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, KROS had revenue of $15.01 million and -$83.16 million in losses. Loss per share was -$3.10.
| Revenue | 15.01M |
| Gross Profit | -58.35M |
| Operating Income | -98.47M |
| Pretax Income | -86.10M |
| Net Income | -83.16M |
| EBITDA | -96.87M |
| EBIT | -98.47M |
| Loss Per Share | -$3.10 |
Balance Sheet
The company has $257.61 million in cash and $15.72 million in debt, with a net cash position of $241.88 million or $12.20 per share.
| Cash & Cash Equivalents | 257.61M |
| Total Debt | 15.72M |
| Net Cash | 241.88M |
| Net Cash Per Share | $12.20 |
| Equity (Book Value) | 262.32M |
| Book Value Per Share | 13.23 |
| Working Capital | 254.73M |
Cash Flow
In the last 12 months, operating cash flow was -$47.99 million and capital expenditures -$494,000, giving a free cash flow of -$48.49 million.
| Operating Cash Flow | -47.99M |
| Capital Expenditures | -494,000 |
| Depreciation & Amortization | 1.60M |
| Net Borrowing | n/a |
| Free Cash Flow | -48.49M |
| FCF Per Share | -$2.45 |
Margins
| Gross Margin | n/a |
| Operating Margin | -655.84% |
| Pretax Margin | -573.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 33.15% |
| Shareholder Yield | 33.15% |
| Earnings Yield | -41.16% |
| FCF Yield | -24.00% |
Analyst Forecast
The average price target for KROS is $19.83, which is 86.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.83 |
| Price Target Difference | 86.90% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | -45.59% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 8.22 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.22 |
| Piotroski F-Score | 2 |